Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cencora, Inc. Common Stock
(NY:
COR
)
324.83
+3.48 (+1.08%)
Delayed Quote
Updated: 3:36 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cencora, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release
October 02, 2026
From
Cencora
Via
Business Wire
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off
October 02, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
Wednesday's session: gap up and gap down stock in the S&P500 index
↗
September 30, 2026
Via
Chartmill
1 of Wall Street’s Favorite Stocks with Impressive Fundamentals and 2 We Turn Down
September 28, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via
StockStory
Cencora Elects Robert E. Sanchez to Its Board of Directors
September 25, 2026
From
Cencora
Via
Business Wire
Cencora (NYSE:COR): A Quality Stock With Strong EBIT Growth and Cash Conversion
↗
September 14, 2026
Via
Chartmill
Cencora (NYSE:COR) Shares Tick Up as Fiscal Q3 Results Meet Estimates, Full-Year Guidance Adjusted
↗
August 05, 2026
Via
Chartmill
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027
↗
September 21, 2026
Cencora (NYSE:COR) executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing demand in oncology and retina, expanded physician-services...
Via
MarketBeat
Topics
ETFs
Earnings
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference
↗
September 21, 2026
Cencora (NYSE:COR) executives highlighted the company’s specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference...
Via
MarketBeat
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
↗
September 11, 2026
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.79% on an annualized basis producing an average annual return of 20.35%. Currently, Cencora has a market capitalization of...
Via
Benzinga
2 S&P 500 Stocks with Exciting Potential and 1 We Question
September 10, 2026
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
Via
StockStory
Topics
Stocks
Q2 Earnings Outperformers: Cencora (NYSE:COR) And The Rest Of The Health Insurance Providers Stocks
September 07, 2026
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Cencora (NYSE:COR) and its pe...
Via
StockStory
Topics
Artificial Intelligence
Economy
Fraud
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
↗
August 19, 2026
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.61% on an annualized basis producing an average annual return of 19.99%. Currently, Cencora has a market capitalization of...
Via
Benzinga
"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.
↗
August 19, 2026
These healthcare companies can actually benefit from inflation.
Via
The Motley Fool
Topics
Bonds
Economy
Government
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today
↗
August 13, 2026
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basis producing an average annual return of 19.83%. Currently, Cencora has a market capitalization of...
Via
Benzinga
Cardinal Health Earnings: Can Perfection Get Priced In Twice?
↗
August 12, 2026
Cardinal Health stock hit a new all-time high after mixed earnings, with analyst price target hikes, gene therapy logistics wins and a 29-year dividend growth streak supporting the uptrend.
Via
MarketBeat
Topics
World Trade
Uncover the latest developments among S&P500 stocks in today's session.
↗
August 12, 2026
Via
Chartmill
Cencora (COR) Q3 2026 Earnings Call Transcript
↗
August 12, 2026
Revenue hit $84.8 billion as GLP-1 sales surged 25% despite manufacturer price headwinds.
Via
The Motley Fool
Topics
Earnings
These S&P500 stocks are gapping in today's session
↗
August 12, 2026
Via
Chartmill
Which S&P500 stocks are moving before the opening bell on Wednesday?
↗
August 12, 2026
Via
Chartmill
5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call
August 12, 2026
Cencora’s second quarter was marked by performance that met Wall Street’s expectations on revenue and exceeded consensus on non-GAAP profitability, driving a...
Via
StockStory
Topics
Earnings
Cencora Q3 Earnings Call Highlights
↗
August 06, 2026
Cencora (NYSE:COR) reported fiscal 2026 third-quarter results marked by double-digit adjusted operating income growth, specialty-business momentum and $1 billion in share repurchases, prompting the...
Via
MarketBeat
Topics
ETFs
Earnings
COR Q2 Deep Dive: Specialty Platform and MSO Growth Propel Steady Healthcare Distribution
August 06, 2026
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $84.75 billion. Its non-GAA...
Via
StockStory
Which S&P500 stocks are gapping on Wednesday?
↗
August 05, 2026
Via
Chartmill
Cencora’s (NYSE:COR) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
August 05, 2026
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $84.75 billion. Its non-GAA...
Via
StockStory
Cencora Reports Fiscal 2026 Third Quarter Results
August 05, 2026
From
Cencora
Via
Business Wire
Cencora Earnings: What To Look For From COR
August 03, 2026
Healthcare distributor Cencora (NYSE:COR) will be reporting earnings this Wednesday before market hours. Here’s what you need to know. Cencora missed analyst...
Via
StockStory
Topics
Artificial Intelligence
McKesson's Compounding Keeps Adding Up
↗
July 31, 2026
McKesson posted strong fiscal 2026 results, raised guidance, boosted buybacks and its dividend, and maintains a Moderate Buy rating from analysts amid its evolving specialty business mix.
Via
MarketBeat
Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers
July 12, 2026
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Cencora (NYSE:COR) and its pe...
Via
StockStory
Topics
Artificial Intelligence
Economy
Fraud
3 Market-Beating Stocks for Long-Term Investors
July 09, 2026
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
